Clinical outcomes and safety of combined calcitriol and bisphosphonates in treating postmenopausal osteoporosis: a retrospective cohort study

被引：0
|
作者：
Xu Zhou [1 ]
Hui Long [2 ]
Jui-Hua Wang [2 ]
Zhen Huang [3 ]
Liping Cao [4 ]
机构：
[1] Central South University,Department of Reproductive Medicine, Xiangya Hospital
[2] Central South University,National Clinical Research Center of Geriatric Disorders, Xiangya Hospital
[3] Central South University,Department of Emergency, Xiangya Hospital
[4] Hunan Yueya Dental Clinic,undefined
[5] Changsha Chang Hao Hospital,undefined
来源：
Journal of Orthopaedic Surgery and Research | / 20卷 / 1期
关键词：
Calcitriol; Bisphosphonates; Postmenopausal OP; Clinical efficacy; Safety evaluation; Retrospective study;
D O I：
10.1186/s13018-025-05714-2
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] RETRACTED: Clinical Efficacy and Safety Evaluation of Calcitriol Combined with Bisphosphonates in the Therapy of Postmenopausal Osteoporosis: Based on a Retrospective Cohort Study (Retracted Article)
    Jing, Weibing
    Dai, Yankun
    Zhu, Jinxin
    Deng, Suqin
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [2] Clinical efficacy and outcomes of calcitriol combined with bisphosphonates in the treatment of postmenopausal osteoporosis: A quasi-experimental study
    Han, Kui
    Wang, Xiaoyan
    MEDICINE, 2024, 103 (45)
  • [3] RETRACTION: Clinical Efficacy and Safety Evaluation of Calcitriol Combined with Bisphosphonates in the Therapy of Postmenopausal Osteoporosis: Based on a Retrospective Cohort Study (vol 2022,2711938,2022)
    Jing, W.
    Dai, Y.
    Zhu, J.
    Deng, S.
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [4] Effects of bisphosphonates combined with calcitriol in treating osteoporosis induced by endocrine therapy for breast cancer
    Ou, Linyang
    Lei, Ruiwen
    Wu, Wanming
    Guo, Yan
    Huang, Renfeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (10): : 5684 - 5691
  • [5] The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis
    Suh, Hee-Won
    Kim, Hyun-Ok
    Kim, Young Sik
    Sunwoo, Sung
    Lee, Jung Ah
    Lee, Hye-Ree
    Kim, Byungsung
    Kim, Dae Hyun
    Choi, Youn Seon
    Cheong, Yoo Seock
    Yum, Keunsang
    Yang, Yun Jun
    Yu, Byung-Yeon
    Cho, Chung Hwan
    Park, Sat-Byul
    Shin, Dong Hyeok
    KOREAN JOURNAL OF FAMILY MEDICINE, 2012, 33 (06): : 346 - 355
  • [6] A clinical study of Yigu capsule in treating postmenopausal osteoporosis
    Zhang Rong-hua
    Chen Ke-ji
    Lu Da-xiang
    Zhu Xiao-feng
    Ma Xiao-chang
    Chinese Journal of Integrative Medicine, 2005, 11 (2) : 97 - 103
  • [7] Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study
    Huang, Zhenna
    Liao, Tzu-Chi
    Chuang, Albert Tzu-Ming
    Shao, Shih-Chieh
    Lange, Jeff
    Lin, Tzu-Chieh
    Kim, Min
    Lai, Edward Chia-Cheng
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (03) : 465 - 473
  • [8] Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice
    Patricia Sieber
    Patrizia Lardelli
    Claude A. Kraenzlin
    Marius E. Kraenzlin
    Christian Meier
    Clinical Drug Investigation, 2013, 33 : 117 - 122
  • [9] Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice
    Sieber, Patricia
    Lardelli, Patrizia
    Kraenzlin, Claude A.
    Kraenzlin, Marius E.
    Meier, Christian
    CLINICAL DRUG INVESTIGATION, 2013, 33 (02) : 117 - 122
  • [10] Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
    Pazianas, Michael
    Cooper, Cyrus
    Ebetino, F. Hal
    Russell, R. Graham G.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 325 - 343
12345